Two NIH grants are looking at developing new antidotes against fentanyl overdose
The SMARRT program, developed through a T32 grant from the NIH, promotes an entire curriculum of scholarship, training and mentoring for participants
Research led by Cleveland Alzheimer's Disease Center could foster collaboration and help identify novel therapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement